(Reuters) -Indian shares gave up opening gains to inch lower on Friday, as worries over moderation in corporate earnings ...

Dr Reddy’s Laboratories share price declined more than 6% in the morning trades on Friday post Q3 results that were announced after the market hours of Thursday ...

Donald Trump's swearing-in ceremony, Davos and Q3 earnings are among the major events that took place this week.

Dr Reddy’s Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third ...

Shares of Dr Reddy’s Laboratories on Friday ended 5 per cent lower after the company's third-quarter earnings failed to cheer ...

Shares of Dr Reddy's Laboratories fell by 5% as the company's third-quarter profit rise failed to impress investors. The ...

Retail and banking stocks rose 0.5 per cent and 0.7 per cent, respectively. NEW DELHI: Vodafone Idea(numbers of share traded: ...

The Nifty 50 fell 0.49% to 23,092.2 on the day, while the BSE Sensex shed 0.43% to 76,190.46. Both indexes swung between ...

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

Indian shares closed lower on Friday after a choppy session. Markets gave up early gains as concerns about slowing earnings growth ...

Dr. Reddy's Laboratories Ltd. 500124 shares slid 5.01% to 1,224.70 Indian rupees Friday, on what proved to be an all-around ...

Amid sharp losses in sectoral indices together with broader markets, Indian equities after zooming substantially intraday ...